Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

People living with diabetes not managing night-time hypos, survey shows

October 6, 2022
admin
A new survey has found that a third of people failed to report night-time hypoglycaemia [hypos] to their doctor or nurse despite the impact they have on the lives of people living with the condition.

Older people underestimate risk of falls

October 6, 2022
admin
People in all age groups are under-estimating their risk of falling, a new survey has found.  The Saga Populus survey of 9,521 people aged between 50 and 79 years old found that every age group significantly underestimated their risk of falling. 

Gut expert urges more faecal microbiota transplants to treat C.Diff infections

October 6, 2022
admin
More faecal transplants and less antibiotics should be used to counter the rise of Clostridium Difficile infection, a leading microbiologist has claimed.

West Midlands mental health trusts form alliance to transform provision of acute mental health services

October 6, 2022
admin
Four mental health trusts in the West Midlands have come together in a new healthcare alliance to transform the way acute mental health services are provided.

Empagliflozin shown to reduce cardiovascular risk in diabetes patients, new trial data reveals

October 6, 2022
admin
Empagliflozin (Jardiance) has been proven to 'significantly' reduce cardiovascular risk in patients with diabetes, data from a dedicated trial has revealed.

CHMP grants positive opinion for reversal agent idarucizumab

October 6, 2022
admin
The Committee for Medicinal Products for Human use (CHMP) of the European Medicines Agency has issued a positive opinion recommending European approval for the use of idarucizumab when needing to quickly revere the effects of dabigatran etexilate (Pradaxa).

EC approves Zalviso for post-operative pain

October 6, 2022
admin
The European Commission (EC) has approved Zalviso (15 micrograms sublingual tablets) for the management of acute moderate to severe post-operative pain in adult patients. 

Over fifty per cent do not go for new bowel cancer test

October 6, 2022
admin
MORE than half of people invited to take a new bowel cancer screening test didn't take up the opportunity €“ even though it could stop them developing or dying from the disease, according to a Cancer Research UK report published in the Journal of Medical Screening.

NICE recommend edoxaban for preventing stroke in AF

October 6, 2022
admin
NICE has recommended a new treatment edoxaban (Lixiana) to help prevent stroke and systemic embolism (SE) in patients suffering from the heart rhythm disorder atrial fibrillation (AF). 

New oral antiplatelets and anticoagulants in general practice: Part 1

October 6, 2022
Dr Jane Wilcock
This series discusses two new antiplatelet and four new oral anticoagulant (OAC) medications that GPs are increasingly finding on routine repeat prescriptions In healthy individuals, a number of factors constantly balance thrombus formation and fibrinolysis.

Sleep disordered breathing in children: Who, when and how to investigate?

April 23, 2024
Dr Michael Yanney
Sleep disordered breathing (SDB) is a spectrum of disease characterised by abnormal breathing patterns and adverse consequences of sleep disturbance.

Women and anaemia

October 6, 2022
Dr Andrew Blann
In this article the author considers the causes of anaemia in women

Lung Cancer in Primary Care

April 19, 2024
Dr Ernie Marshall
The authors look at how new NICE guidelines on referral will impact the quality of care for people living with lung cancer

New diabetes combination treatment shows positive results

October 6, 2022
admin
A new treatment that combines long acting (basal) insulin (insulin degludec, Tresiba) and GLP-1 receptor agonist (liraglutide, Victoza) in one pen has posted positive results at the 51st European Association for the Study of Diabetes Annual Meeting. 

Better communication may improve diabetes care

October 6, 2022
admin
The perception of diabetes, and the impact it has on health, greatly differs between people living with type 2 diabetes who are uncontrolled on basal insulin and physicians, a new study has revealed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy